Canadian Venture Development Company Achieves Key Milestone with Completion of Successful Commercial Pilot Program of Its MPowRx Anti-Snoring Appliance
Calgary, Canada, May 03, 2008 --(PR.com)-- Calgary based Tech Avenue Ventures Corp. announced today that it has concluded a successful commercial pilot program for its clinically proven MPowRx anti-snoring appliance in association with four dental clinics, in Calgary, Alberta, selected for their demonstrated leadership in adopting innovative technologies.
The response from participating clinics in the pilot program was very positive. “We found outstanding acceptance for the MPowRx appliance from our patients, who greatly appreciated the affordability of this new product”, says Dr. Stephan Hrach of Kearns, Hunt & Hrach Dental Care. “It is exciting to have an effective tool available that can be offered to a broader patient base,” adds Dr. Hrach.
The MPowRx Snoring Solution was developed by Calgary dental researcher Dr. Leslie Dort MSc, DDS Dip ABDSM, to address the large unmet need for a simple, economical and clinically effective over-the-counter (OTC) solution for snoring, which impacts nearly 60 million people in North America. A substantial number of sufferers (98 percent) simply ignore their condition or seek the convenience of over-the-counter remedies that lack clinical efficacy. More effective custom devices are available but come at high expense and inconvenience resulting in very low adoption of these treatment options. The MPowRx device breaks down these barriers, giving patients an effective “first line” treatment option at an affordable price.
The pilot dental program was designed to measure consumer acceptance, product efficacy in a non-clinical setting and fine tune the marketing and distribution strategy for Canada. “The pilot program has exceeded our expectations on every level,” says Gijs van Rooijen of Tech Avenue Ventures, “and we are accelerating plans for a full scale national launch of the MPowRx Snoring Solution. We are thrilled that all participating clinics will continue to offer the MPowRx appliance as part of their dental practices”, adds van Rooijen.
Participating clinics in the MPowRx commercial pilot program in Calgary included: Dr Larry Stanleigh Dental Clinic, Next Dimension Dentistry, Kearns, Hunt and Hrach Dental Care and Alpha Dental Care.
MPowRx is a trademark of MPowRx Health and Wellness Products Inc. More information on MPowRX Snoring Solution is available at www.mpowrx.com
About Tech Avenue Ventures Corp
Tech Avenue Ventures Corp, incorporated in December 2005 and based in Calgary, Alberta, is a venture development company focused on accelerating the commercialization of high value consumer and medical products. Tech Avenue Ventures is leveraging its life sciences management and core expertise in the areas of sales and marketing, research and development, manufacturing, and intellectual property to guide the development and commercialization process and build profitable companies. More information can be accessed at www.taventures.ca.
Business Contact: Gijs van Rooijen, Ph.D. Co-Founder
Tech Avenue Ventures Corp.
vanro@taventures.ca
403.671.4627
###
The response from participating clinics in the pilot program was very positive. “We found outstanding acceptance for the MPowRx appliance from our patients, who greatly appreciated the affordability of this new product”, says Dr. Stephan Hrach of Kearns, Hunt & Hrach Dental Care. “It is exciting to have an effective tool available that can be offered to a broader patient base,” adds Dr. Hrach.
The MPowRx Snoring Solution was developed by Calgary dental researcher Dr. Leslie Dort MSc, DDS Dip ABDSM, to address the large unmet need for a simple, economical and clinically effective over-the-counter (OTC) solution for snoring, which impacts nearly 60 million people in North America. A substantial number of sufferers (98 percent) simply ignore their condition or seek the convenience of over-the-counter remedies that lack clinical efficacy. More effective custom devices are available but come at high expense and inconvenience resulting in very low adoption of these treatment options. The MPowRx device breaks down these barriers, giving patients an effective “first line” treatment option at an affordable price.
The pilot dental program was designed to measure consumer acceptance, product efficacy in a non-clinical setting and fine tune the marketing and distribution strategy for Canada. “The pilot program has exceeded our expectations on every level,” says Gijs van Rooijen of Tech Avenue Ventures, “and we are accelerating plans for a full scale national launch of the MPowRx Snoring Solution. We are thrilled that all participating clinics will continue to offer the MPowRx appliance as part of their dental practices”, adds van Rooijen.
Participating clinics in the MPowRx commercial pilot program in Calgary included: Dr Larry Stanleigh Dental Clinic, Next Dimension Dentistry, Kearns, Hunt and Hrach Dental Care and Alpha Dental Care.
MPowRx is a trademark of MPowRx Health and Wellness Products Inc. More information on MPowRX Snoring Solution is available at www.mpowrx.com
About Tech Avenue Ventures Corp
Tech Avenue Ventures Corp, incorporated in December 2005 and based in Calgary, Alberta, is a venture development company focused on accelerating the commercialization of high value consumer and medical products. Tech Avenue Ventures is leveraging its life sciences management and core expertise in the areas of sales and marketing, research and development, manufacturing, and intellectual property to guide the development and commercialization process and build profitable companies. More information can be accessed at www.taventures.ca.
Business Contact: Gijs van Rooijen, Ph.D. Co-Founder
Tech Avenue Ventures Corp.
vanro@taventures.ca
403.671.4627
###
Contact
Tech Avenue Ventures
Rodger Roeser
859.291.4302
www.taventures.ca
Rodger Roeser
859.291.4302
www.taventures.ca
Contact
Categories